Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021
Market Capitalization	22,647	9,785	8,290	2,716	2,659	3,324
Market Cap Growth	178.95%	18.04%	205.24%	2.14%	-20.00%	-5.41%
Enterprise Value	25,770	11,901	9,264	5,237	4,683	5,412
Last Close Price	5.30	2.29	1.94	1.43	1.40	1.68
PE Ratio	-	-	-	-	-	12.28
PS Ratio	3.54	2.18	3.75	0.93	0.98	1.09
PB Ratio	11.37	5.92	3.27	3.49	2.43	2.35
P/TBV Ratio	11.44	5.99	3.27	3.49	2.43	2.35
P/FCF Ratio	26.85	-	-	-	-	1693.09
P/OCF Ratio	17.69	24.70	-	20.49	-	9.61
EV/Sales Ratio	4.03	2.65	4.19	1.79	1.73	1.78
EV/EBITDA Ratio	8.75	6.07	21.81	54.54	49.41	8.47
EV/EBIT Ratio	9.24	6.50	31.01	-	-	9.86
EV/FCF Ratio	30.55	-	-	-	-	2756.94
Debt / Equity Ratio	2.65	3.26	1.73	4.68	3.05	2.15
Debt / EBITDA Ratio	1.79	2.74	10.33	35.20	35.15	4.64
Debt / FCF Ratio	6.26	-	-	-	-	1551.72
Asset Turnover	0.56	0.41	0.27	-	0.43	0.48
Inventory Turnover	1.09	1.19	0.79	-	1.02	1.12
Quick Ratio	0.28	0.35	0.45	0.48	0.63	1.53
Current Ratio	0.66	0.58	0.76	1.00	1.24	2.28
Return on Equity (ROE)	-45.40%	-42.27%	-108.42%	-	-8.74%	20.13%
Return on Assets (ROA)	15.14%	10.33%	2.24%	-	-0.24%	5.41%
Return on Capital (ROIC)	26.41%	16.40%	3.29%	-	-0.35%	7.60%
Return on Capital Employed (ROCE)	112.10%	85.50%	9.80%	-	-	13.20%
Earnings Yield	-3.78%	-9.05%	-21.68%	-11.97%	-4.12%	8.14%
FCF Yield	3.72%	-3.13%	-20.62%	-41.87%	-45.31%	0.06%
Dividend Yield	-	-	-	-	-	4.17%
Payout Ratio	-	-	-	-	-	45.62%
Buyback Yield / Dilution	-14.42%	-	-125.00%	-	-	-
Total Shareholder Return	-14.42%	-	-125.00%	-	-	4.17%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.